BOSTON, Feb 21 (Reuters) - The chief financial officer of Vanda Pharmaceuticals Inc. has exercised options to sell 3,300 of the drug company's shares, even as it is trying to sell itself or find a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results